For information on the Genomics Platform’s Available Products and Services, please visit our Genomic Services website.
The Broad Institute’s Genomics Platform brings together over 20 years of experience in the management of advanced technologies, applications development, data management, and high-throughput processes relating to sample handling, genotyping, gene expression, and genome sequencing.
This dynamic, integrated platform provides comprehensive genomic services to the scientific community and continues to push the boundaries of the genomic frontier through the application of operational excellence, advanced process design, data analysis and visualization, and technology development. The Genomics Platform explores, validates, optimizes, and implements new technologies, methods and analysis tools to make them widely available.
We service the internal and external community by providing a range of products and services through Broad Institute Genomic Services, which provides the necessary infrastructure to provide the highest quality services and data to drive genomic discovery.
Clinical Research Sequencing Platform
The Broad Clinical Research Sequencing Platform is a clinical laboratory licensed by the State of Massachusetts (License No 3306) and is registered with the Centers for Medicare and Medicaid Services to provide testing under the CLIA regulations.
CRSP is the route for physicians and physician-researchers to access high quality molecular tests such as Whole Exome Sequencing offered by the Broad Institute in a CLIA setting.
The CRSP team is working on an array of additional assays and analytical tools to be validated and released in coming months. These include Firehose analysis modules including MuTect3 and InDelocator for the analysis of tumor-normal pairs from cancer patients. Also coming soon is a Broad-designed, comprehensive cancer targeted panel.